Literature DB >> 31276312

Clinical efficacy of a new cetylpyridinium chloride-hyaluronic acid-based mouthrinse compared to chlorhexidine and placebo mouthrinses-A 21-day randomized clinical trial.

Santosh Kumar Tadakamadla1, Venkata V Bharathwaj2, Prabu Duraiswamy2, Chiarella Sforza3,4, Gianluca M Tartaglia3,5.   

Abstract

OBJECTIVE: To compare the effectiveness of a novel cetylpyridinium chloride (CPC)-hyaluronic acid (HA)-based mouthrinse with chlorhexidine (CHX) and placebo mouthrinses in preventing plaque and gingivitis. The secondary outcomes were calculus, extrinsic stains, oral malodour and occurrence of adverse events.
METHODS: A 21-day randomized, double-blind, three-arm parallel study with random allocation of young dental students to any of the three mouthrinse groups. Thorough prophylaxis was done at baseline followed by a baseline examination for oral malodour, extrinsic stains, calculus, gingivitis and plaque by a single examiner. All the subjects used the allocated mouthrinse twice daily for 21 days and were examined again at the end of the experimental period. They were also interviewed for adverse events. Change in the scores of clinical indices was calculated and compared between the groups.
RESULTS: A total of 75 subjects were included and completed the experiment. There was a significant difference for change in plaque index scores between the groups (P = .015); subjects in the placebo group experienced higher levels of plaque accumulation than the other groups. Teeth staining increased in the CHX (P < .001) and placebo groups (P = .002), but not in CPC-HA users (P = .573). No significant differences were found between the three experimental groups for change in the gingival index (P = .08), calculus scores (P = .494), oral malodour (P = .870) and reporting of adverse events (P = .249).
CONCLUSIONS: CPC-HA and CHX had similar effectiveness in preventing plaque accumulation, while no differences were observed between the mouthrinses for preventing gingivitis. Dental staining was caused by CHX and the placebo mouthrinses but not by CPC-HA mouthrinse.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse effects; cetylpyridinium chloride; hyaluronic acid; mouthrinse; therapeutic use

Year:  2019        PMID: 31276312     DOI: 10.1111/idh.12413

Source DB:  PubMed          Journal:  Int J Dent Hyg        ISSN: 1601-5029            Impact factor:   2.477


  4 in total

1.  Theoretical study on charge distribution in cetylpyridinium cationic surfactant.

Authors:  Maksym Fizer; Oksana Fizer
Journal:  J Mol Model       Date:  2021-06-16       Impact factor: 1.810

2.  Evaluation of the effectiveness of a novel mouth rinse containing hyaluronic acid and hydrogen peroxide on gingivitis: A randomized pilot controlled trial.

Authors:  Elisa Boccalari; Santosh Kumar Tadakamadla; Chiara Occhipinti; Valentina Lanteri; Cinzia Maspero
Journal:  Clin Exp Dent Res       Date:  2022-02-22

Review 3.  Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases.

Authors:  Meenakshi Rajendiran; Harsh M Trivedi; Dandan Chen; Praveen Gajendrareddy; Lin Chen
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

4.  Diffusion of Vanadium Ions in Artificial Saliva and Its Elimination from the Oral Cavity by Pharmacological Compounds Present in Mouthwashes.

Authors:  Sónia I G Fangaia; Ana M T D P V Cabral; Pedro M G Nicolau; Fernando A D R A Guerra; M Melia Rodrigo; Ana C F Ribeiro; Artur J M Valente; Miguel A Esteso
Journal:  Biomolecules       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.